Results: AVN was found in 11 of 127 8.7% SLE patients.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: Avascular necrosis AVN is the death of bone due to compromise of blood flow.
📊
Key Findings & Data:The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus SLE is the most common underlying disease.
💡
Conclusion & Impact:Results: AVN was found in 11 of 127 8.7% SLE patients.
Background/aim: Avascular necrosis AVN is the death of bone due to compromise of blood flow. The etiology of AVN is multifactorial; corticosteroid usage is the second most significant factor after trauma, and systemic lupus erythematosus SLE is the most common underlying disease. The objective of this study was to assess the factors of AVN in SLE patients. Materials and methods: The study included 127 patients with SLE who fulfilled 1997 American College of Rheumatology ACR revised criteria. Demographic data, age at SLE diagnosis, disease duration, disease activity, body mass index, clinical findings, antiphospholipid syndrome, steroid usage, dose and duration, comorbid diseases, and smoking history were recorded. Results: AVN was found in 11 of 127 8.7% SLE patients. Hyperlipidemia P
DOĞAN, İ., KALYONCU, U., KILIÇ, L., AKDOĞAN, A., KARADAĞ, Ö., KİRAZ, S., BİLGEN, Ş. Ş. A., ERTENLİ, A. İ. (2020). Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 1, 219–224. https://ajindex.com/articles/113243
Fukushima W, Fujioka M, Kubo T, Tamakoshi A, Nagai M et al. Nationwide epidemiologic survey of idiopathic osteonecrosis of the femoral head. Clinical Orthophedics and Related Research 2010; 468: 2715-2724
Dubois E, Cozen L. Avascular necrosis associated with lupus erythematosus. Journal of the American Medical Association 1960; 174: 966-971
Joo YB, Sung YK, Shim JS, Kim JH, Lee EK et al. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: A nationwide epidemiologic study. Rheumatology International 2015; 35: 879-886
Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Seminars in Arthritis and Rheumatism 2002; 32: 94-124
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatology 1997; 40: 1725
Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis & Rheumatology 1999; 42: 1354-1360
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis & Rheumatology 1999; 42: 1309-1311
Sekiya F, Yamaji K, Yang K, Tsuda H, Takasaki Y. Investigation of occurrence of osteonecrosis of the femoral head after increasing corticosteroids in patients with recurring systemic lupus erythematosus. Rheumatology International 2010; 30: 1587-1593
Sagakuchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. Journal of Orthopedic Science 2010; 15: 185- 191
Gladman DD, Dhillon N, Su J, Urowitz MB. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors. Lupus 2018; 27 (1): 76-81. doi: 10.1177/0961203317711012 11. Sayarlioglu M, Yuzbsioglu N, Inanc M, Kamali S, Cefle A et al. Risk factors for avascular bone necrosis in patients with systemic lupus erythematosus. Rheumatology International 2012; 32: 177-182
Heshin-Bekenstein M, Trupin L, Yelin E, von Scheven E, Yazdany J et